• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载曲安奈德的控释 mPEG-PLGA 纳米粒治疗实验性自身免疫性葡萄膜炎的评价。

Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.

机构信息

Shandong Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Diseases; Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Therapy of Ocular Diseases in Universities of Shandong; Eye Institute of Shandong University of Traditional Chinese Medicine, Jinan, 250002, People's Republic of China.

出版信息

Nanotechnology. 2019 Apr 19;30(16):165702. doi: 10.1088/1361-6528/aafe36. Epub 2019 Jan 14.

DOI:10.1088/1361-6528/aafe36
PMID:30641491
Abstract

Uveitis is a recurrent, sight-threatening intraocular inflammatory disease and is treated with glucocorticoids in clinical practice. In the present study, methoxypoly(ethyleneglycol)-poly(dl-lactide-co-glycolic acid) (mPEG-PLGA) nanoparticles in combination with triamcinolone acetonide (TA) were fabricated using a modified double emulsification method. Further, we characterized the TA-loaded nanoparticles, and investigated the effects of TA-loaded nanoparticles on experimental autoimmune uveitis rats, including histopathological examination and the alterations in interleukin (IL)-17 and IL-10 at mRNA and protein levels in either aqueous humor or serum. As a result, the TA-loaded nanoparticles were a well-defined spherical shape with a mean particle size of 82 nm. The in vitro release profile showed that the TA-loaded nanoparticles could sustain for more than 45 days, and possessed higher anti-inflammatory effects compared to TA alone after pathological examination, resulting in decreased IL-17 and elevated IL-10 levels in both aqueous humor and serum. Based on these findings, it can be concluded that TA-loaded mPEG-PLGA nanoparticles can potentially provide a better anti-inflammatory effect in treating chronic and recurrent uveitis in clinical practice.

摘要

葡萄膜炎是一种反复发作、威胁视力的眼内炎症性疾病,在临床实践中用糖皮质激素治疗。在本研究中,采用改良的双重乳化法制备了甲氧基聚(乙二醇)-聚(dl-乳酸-co-乙醇酸)(mPEG-PLGA)纳米粒与曲安奈德(TA)的结合物。进一步,我们对载 TA 的纳米粒进行了表征,并研究了载 TA 的纳米粒对实验性自身免疫性葡萄膜炎大鼠的影响,包括组织病理学检查以及房水或血清中白细胞介素(IL)-17 和 IL-10 在 mRNA 和蛋白水平的变化。结果,载 TA 的纳米粒呈定义明确的球形,平均粒径为 82nm。体外释放曲线表明,载 TA 的纳米粒可以持续 45 天以上,并且在病理检查后与单独 TA 相比具有更高的抗炎效果,导致房水和血清中 IL-17 降低和 IL-10 升高。基于这些发现,可以得出结论,载 TA 的 mPEG-PLGA 纳米粒在治疗慢性和复发性葡萄膜炎方面可能提供更好的抗炎效果。

相似文献

1
Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.载曲安奈德的控释 mPEG-PLGA 纳米粒治疗实验性自身免疫性葡萄膜炎的评价。
Nanotechnology. 2019 Apr 19;30(16):165702. doi: 10.1088/1361-6528/aafe36. Epub 2019 Jan 14.
2
RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.撤回:脉络膜新生血管和可生物降解聚合物粒径对曲安奈德经巩膜缓释输送的影响。
Int J Pharm. 2012 Sep 15;434(1-2):140-7. doi: 10.1016/j.ijpharm.2012.05.025. Epub 2012 May 23.
3
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.聚合物曲安奈德纳米载药系统治疗葡萄膜炎的研究:体内外实验。
Eur J Pharm Biopharm. 2013 May;84(1):63-71. doi: 10.1016/j.ejpb.2012.12.010. Epub 2013 Jan 5.
4
Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.玻璃体内注射载有曲安奈德的聚乳酸-乙醇酸微球对兔葡萄膜炎模型治疗效果的评估。
Int Ophthalmol. 2014 Jun;34(3):465-76. doi: 10.1007/s10792-013-9829-0. Epub 2013 Jul 19.
5
Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.使用曲安奈德的可生物降解聚β-氨基酯纳米粒在兔眼模型中增强抗炎作用。
Invest Ophthalmol Vis Sci. 2013 Aug 15;54(8):5520-6. doi: 10.1167/iovs.13-12296.
6
Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.载三氯醋酸曲安奈德的脂质纳米囊用于眼部应用。
Int J Pharm. 2020 Jan 5;573:118795. doi: 10.1016/j.ijpharm.2019.118795. Epub 2019 Nov 1.
7
Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.抗炎药物的超分子水凝胶的糖基化增强生物相容性,可用于局部抑制炎症。
Acta Biomater. 2018 Jun;73:275-284. doi: 10.1016/j.actbio.2018.04.019. Epub 2018 Apr 13.
8
Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation.载三氯醋酸曲安奈德 PLGA-壳聚糖纳米粒经眼部给药治疗眼内炎症。
Artif Cells Nanomed Biotechnol. 2021 Dec;49(1):308-316. doi: 10.1080/21691401.2021.1895184.
9
Directing the nanoparticle formation by the combination with small molecular assembly and polymeric assembly for topical suppression of ocular inflammation.通过与小分子组装和聚合物组装相结合来控制纳米颗粒的形成,以局部抑制眼部炎症。
Int J Pharm. 2018 Nov 15;551(1-2):223-231. doi: 10.1016/j.ijpharm.2018.09.015. Epub 2018 Sep 10.
10
Triamcinolone acetonide-loaded PLA/PEG-PDL microparticles for effective intra-articular delivery: synthesis, optimization, in vitro and in vivo evaluation.载曲安奈德的 PLA/PEG-PDL 微球用于有效的关节腔内递药:合成、优化、体外和体内评价。
J Control Release. 2019 Sep 10;309:125-144. doi: 10.1016/j.jconrel.2019.07.030. Epub 2019 Jul 22.

引用本文的文献

1
Nano-based drug delivery systems for the treatment of non-infectious uveitis.用于治疗非感染性葡萄膜炎的纳米药物递送系统。
Adv Ophthalmol Pract Res. 2024 Nov 12;5(2):124-134. doi: 10.1016/j.aopr.2024.11.003. eCollection 2025 May-Jun.
2
Biopolymeric Innovations in Ophthalmic Surgery: Enhancing Devices and Drug Delivery Systems.眼科手术中的生物聚合物创新:改进器械与药物递送系统
Polymers (Basel). 2024 Jun 16;16(12):1717. doi: 10.3390/polym16121717.
3
A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions.
眼科治疗的新时代:用于葡萄膜炎和神经眼科疾病的先进药物递送系统
Pharmaceutics. 2023 Jul 14;15(7):1952. doi: 10.3390/pharmaceutics15071952.
4
Immune modulating nanoparticles for the treatment of ocular diseases.免疫调节纳米颗粒治疗眼部疾病。
J Nanobiotechnology. 2022 Nov 24;20(1):496. doi: 10.1186/s12951-022-01658-5.
5
Assessment of Efficacy and Safety Using PPAR-γ Agonist-Loaded Nanocarriers for Inflammatory Eye Diseases.使用过氧化物酶体增殖物激活受体-γ 激动剂负载的纳米载体评估炎症性眼病的疗效和安全性。
Int J Mol Sci. 2022 Sep 23;23(19):11184. doi: 10.3390/ijms231911184.
6
Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis.纳米喷雾干燥器对吡格列酮聚合物纳米系统的稳定作用:研发、体内、体外及同步加速器分析
Pharmaceutics. 2021 Oct 20;13(11):1751. doi: 10.3390/pharmaceutics13111751.
7
Injectable polymeric nanoparticle hydrogel system for long-term anti-inflammatory effect to treat osteoarthritis.用于治疗骨关节炎的具有长期抗炎作用的可注射聚合物纳米颗粒水凝胶系统。
Bioact Mater. 2021 Jul 7;7:14-25. doi: 10.1016/j.bioactmat.2021.05.028. eCollection 2022 Jan.
8
Nanotechnology for the Treatment of Allergic Conjunctival Diseases.用于治疗过敏性结膜疾病的纳米技术
Pharmaceuticals (Basel). 2020 Oct 29;13(11):351. doi: 10.3390/ph13110351.
9
Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and evaluation in a rabbit ocular inflammatory model.用于曲安奈德眼部递药的聚合物胶束:在兔眼炎性模型中的制备和评价。
Drug Deliv. 2020 Dec;27(1):1115-1124. doi: 10.1080/10717544.2020.1797241.
10
Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation.用于治疗眼表炎症的局部眼用给药系统的设计进展及其生物药剂学评价
Pharmaceutics. 2020 Jun 19;12(6):570. doi: 10.3390/pharmaceutics12060570.